Supplementary Figure S7 from Jak2<sup>V617F</sup> Reversible Activation Shows Its Essential Requirement in Myeloproliferative Neoplasms
Andrew J. Dunbar,Robert L. Bowman,Young C. Park, Kavi O'Connor,Franco Izzo,Robert M. Myers, Abdul Karzai,Zachary Zaroogian,Won Jun Kim, Inés Fernández-Maestre,Michael R. Waarts, Abbas Nazir,Wenbin Xiao,Tamara Codilupi,Max Brodsky,Mirko Farina,Louise Cai,Sheng F. Cai,Benjamin Wang,Wenbin An,Julie L. Yang,Shoron Mowla, Shira E. Eisman,Amritha Varshini Hanasoge Somasundara,Jacob L. Glass,Tanmay Mishra, Remie Houston, Emily Guzzardi, Anthony R. Martinez Benitez,Aaron D. Viny,Richard P. Koche,Sara C. Meyer,Dan A. Landau,Ross L. Levine crossref（2024）
摘要
Differential gene expression responses of Jak2V617F deletion compared to JAK inhibitor therapy
查看译文
AI 理解论文
溯源树
样例
